avatar for Dayna Lesueur

Dayna Lesueur

Alnylam Pharmaceuticals, Inc.
Regulatory Affairs Post-PharmD Fellow
Dayna graduated with her PharmD in May of 2016 and is currently completing a 2-year Fellowship in Regulatory Strategy at Alnylam Pharmaceuticals, a pre-commercial biotechnology company developing RNA interference (RNAi) in the rare disease space. Dayna's focus at Alnylam so far has been with the development of Fitusiran, the companies Hemophilia product. Dayna is also pursing a Masters in Regulatory Affairs.

My Speakers Sessions

Tuesday, June 20

9:30am CDT